Cefacetrile
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
(6R,7R)-3-(acetyloxymethyl)-7-[(2-cyanoacetyl)amino]-
8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid |
|
Clinical data | |
Trade names | Celospor, Celtol, Cristacef |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration |
Intravenous, intramuscular, intramammary |
Pharmacokinetic data | |
Protein binding | 23 to 38% |
Biological half-life | 1.2 hours |
Excretion | Renal (72%) |
Identifiers | |
CAS Number | 10206-21-0 |
ATC code | J01DB10 (WHO) QJ51DB10 (WHO) |
PubChem | CID: 91562 |
DrugBank | DB01414 |
ChemSpider | 82675 |
UNII | FDM21QQ344 |
KEGG | D07629 |
ChEMBL | CHEMBL2104099 |
Chemical data | |
Formula | C13H13N3O6S |
Molecular mass | 339.325 g/mol |
|
|
|
|
(verify) |
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in gram-positive and gram-negative bacterial infections. It is a bacteriostatic antibiotic.[1][2] Cefacetrile is marketed under the trade names Celospor, Celtol, and Cristacef,[3] and as Vetimast for the treatment of mammary infections in lactating cows.[2]
Synthesis
It was made by reacting 7-ACA (7-aminocephalosporanic acid) with cyanoacetyl chloride in the presence of tributylamine.
References
<templatestyles src="Asbox/styles.css"></templatestyles>